Cargando…

325. Cancer Screening Disparities among Persons Living with HIV (PLWH)

BACKGROUND: Cancer is now the leading cause of mortality for persons living with HIV (PLWH) in the United States, but it is uncertain whether PLWH access cancer screening that could lower this burden. We sought to assess cancer screening for breast, cervical, and colon cancer among PLWH compared wit...

Descripción completa

Detalles Bibliográficos
Autores principales: Hysell, Kristen, He, Wei, Chang, Yuchiao, Dryden-Peterson, Scott, Triant, Virginia A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6810023/
http://dx.doi.org/10.1093/ofid/ofz360.398
_version_ 1783462145233518592
author Hysell, Kristen
He, Wei
Chang, Yuchiao
Dryden-Peterson, Scott
Triant, Virginia A
author_facet Hysell, Kristen
He, Wei
Chang, Yuchiao
Dryden-Peterson, Scott
Triant, Virginia A
author_sort Hysell, Kristen
collection PubMed
description BACKGROUND: Cancer is now the leading cause of mortality for persons living with HIV (PLWH) in the United States, but it is uncertain whether PLWH access cancer screening that could lower this burden. We sought to assess cancer screening for breast, cervical, and colon cancer among PLWH compared with the HIV-uninfected population at a multicenter healthcare system over the past two decades. METHODS: Data were obtained from a prospective, observational HIV clinical care cohort comprised of PLWH engaged in care in the Partners Healthcare System. Patients eligible for cancer screening between the years 2002 and 2016 were included. Patients were matched in a maximum of 1:4 ratio with HIV-uninfected patients from the Massachusetts General Primary Care Practice-Based Research Network based on age, sex, race, year of study entry, and length of follow-up. The mean proportion of time in which eligible patients were guideline concordant for cervical, breast, and colon cancer screening was assessed. Non-parametric tests were used to compared screening rates between PLWH and HIV-infected and on the basis of multiple clinical and sociodemographic factors. RESULTS: During the observation period, a total of 495 PLWH were eligible for breast cancer screening, 1011 for cervical cancer screening, and 1965 for colon cancer screening. For each screening group, the majority of PLWH were on antiretroviral therapy (ART) and had relatively high CD4 cell counts (Table 1). Screening rates for PLWH compared with controls were 67.3% vs. 82.8% (P < 0.0001) for breast cancer, 49.0% vs. 73.3% (P < 0.0001) for cervical cancer, and 92.7% vs. 91.2% (P = 0.96) for colon cancer (Figure 1). Among PLWH, factors significantly associated with lower rates of screening guideline concordance were older age, lower CD4 count, HIV-1 RNA >1000 copies/mL, and HIV duration < 5 years for breast cancer, and older age, white race, English language, and lack of ART use for cervical cancer. CONCLUSION: Among patients engaged in longitudinal care, PLWH had significantly lower rates of screening for breast and cervical cancer than HIV-uninfected. Disparity is not explained by racial or primary language differences. Further work to improve access to cancer screening for PLWH is needed. [Image: see text] [Image: see text] DISCLOSURES: All authors: No reported disclosures.
format Online
Article
Text
id pubmed-6810023
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-68100232019-10-28 325. Cancer Screening Disparities among Persons Living with HIV (PLWH) Hysell, Kristen He, Wei Chang, Yuchiao Dryden-Peterson, Scott Triant, Virginia A Open Forum Infect Dis Abstracts BACKGROUND: Cancer is now the leading cause of mortality for persons living with HIV (PLWH) in the United States, but it is uncertain whether PLWH access cancer screening that could lower this burden. We sought to assess cancer screening for breast, cervical, and colon cancer among PLWH compared with the HIV-uninfected population at a multicenter healthcare system over the past two decades. METHODS: Data were obtained from a prospective, observational HIV clinical care cohort comprised of PLWH engaged in care in the Partners Healthcare System. Patients eligible for cancer screening between the years 2002 and 2016 were included. Patients were matched in a maximum of 1:4 ratio with HIV-uninfected patients from the Massachusetts General Primary Care Practice-Based Research Network based on age, sex, race, year of study entry, and length of follow-up. The mean proportion of time in which eligible patients were guideline concordant for cervical, breast, and colon cancer screening was assessed. Non-parametric tests were used to compared screening rates between PLWH and HIV-infected and on the basis of multiple clinical and sociodemographic factors. RESULTS: During the observation period, a total of 495 PLWH were eligible for breast cancer screening, 1011 for cervical cancer screening, and 1965 for colon cancer screening. For each screening group, the majority of PLWH were on antiretroviral therapy (ART) and had relatively high CD4 cell counts (Table 1). Screening rates for PLWH compared with controls were 67.3% vs. 82.8% (P < 0.0001) for breast cancer, 49.0% vs. 73.3% (P < 0.0001) for cervical cancer, and 92.7% vs. 91.2% (P = 0.96) for colon cancer (Figure 1). Among PLWH, factors significantly associated with lower rates of screening guideline concordance were older age, lower CD4 count, HIV-1 RNA >1000 copies/mL, and HIV duration < 5 years for breast cancer, and older age, white race, English language, and lack of ART use for cervical cancer. CONCLUSION: Among patients engaged in longitudinal care, PLWH had significantly lower rates of screening for breast and cervical cancer than HIV-uninfected. Disparity is not explained by racial or primary language differences. Further work to improve access to cancer screening for PLWH is needed. [Image: see text] [Image: see text] DISCLOSURES: All authors: No reported disclosures. Oxford University Press 2019-10-23 /pmc/articles/PMC6810023/ http://dx.doi.org/10.1093/ofid/ofz360.398 Text en © The Author(s) 2019. Published by Oxford University Press on behalf of Infectious Diseases Society of America. http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
spellingShingle Abstracts
Hysell, Kristen
He, Wei
Chang, Yuchiao
Dryden-Peterson, Scott
Triant, Virginia A
325. Cancer Screening Disparities among Persons Living with HIV (PLWH)
title 325. Cancer Screening Disparities among Persons Living with HIV (PLWH)
title_full 325. Cancer Screening Disparities among Persons Living with HIV (PLWH)
title_fullStr 325. Cancer Screening Disparities among Persons Living with HIV (PLWH)
title_full_unstemmed 325. Cancer Screening Disparities among Persons Living with HIV (PLWH)
title_short 325. Cancer Screening Disparities among Persons Living with HIV (PLWH)
title_sort 325. cancer screening disparities among persons living with hiv (plwh)
topic Abstracts
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6810023/
http://dx.doi.org/10.1093/ofid/ofz360.398
work_keys_str_mv AT hysellkristen 325cancerscreeningdisparitiesamongpersonslivingwithhivplwh
AT hewei 325cancerscreeningdisparitiesamongpersonslivingwithhivplwh
AT changyuchiao 325cancerscreeningdisparitiesamongpersonslivingwithhivplwh
AT drydenpetersonscott 325cancerscreeningdisparitiesamongpersonslivingwithhivplwh
AT triantvirginiaa 325cancerscreeningdisparitiesamongpersonslivingwithhivplwh